Bionomics Limited (BNOX)
NASDAQ: BNOX · Real-Time Price · USD
0.253
+0.011 (4.59%)
At close: Dec 23, 2024, 4:00 PM
0.403
+0.150 (59.38%)
After-hours: Dec 23, 2024, 7:49 PM EST
Bionomics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
24
Market Cap
4.94M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Healthcare Triangle | 16.57M |
| Biomerica | 5.51M |
| Sintx Technologies | 3.25M |
| Predictive Oncology | 1.48M |
| FOXO Technologies | 1.34M |
| Sonnet BioTherapeutics Holdings | 18.63K |
BNOX News
- 7 days ago - Bionomics Announces Supreme Court of New South Wales Approves Bionomics' Re-Domiciliation - GlobeNewsWire
- 11 days ago - Results of Scheme Meeting - GlobeNewsWire
- 20 days ago - Bionomics to Present at the 2024 American College of Neuropsychopharmacology Annual Meeting - GlobeNewsWire
- 21 days ago - Bionomics Reminds Shareholders to Cast their Vote for Re-Domiciliation from Australia to the United States - GlobeNewsWire
- 6 weeks ago - Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement - GlobeNewsWire
- 7 weeks ago - Bionomics Receives Milestone Payment of AUS$1M from Carina Biotech for BNC101 Partnered Legacy Oncology Program - GlobeNewsWire
- 2 months ago - Bionomics to Present at the ThinkEquity Conference - GlobeNewsWire
- 2 months ago - Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC - GlobeNewsWire